Coronavirus pandemic | IndusInd Bank pledges Rs 30 crore towards COVID-19 relief efforts

IndusInd Bank said it has supplied relief materials such as face masks, hand sanitisers and gloves to the affected areas to and is also working on facilitating personal protective equipment (PPE) for medical officials on duty.

PTI

April 16, 2020 / 16:07 IST

live

bselive
nselive

Volume

Todays L/H

Private sector lender IndusInd Bank on Thursday said it has committed Rs 30 crore towards COVID-19 relief efforts. The bank did not specify if it is contributing to any corpus like the PM-CARES Fund and limited itself to saying that it is working with both the central and state governments to fight the pandemic.

It can be noted that a slew of corporates and banks have announced help to the relief efforts since the outbreak last month.

IndusInd Bank said it has supplied relief materials such as face masks, hand sanitisers and gloves to the affected areas to and is also working on facilitating personal protective equipment (PPE) for medical officials on duty.

It has also been given a mandate of opening an account towards the collection of contributions towards Prime Minister's Citizen Assistance and Relief in Emergency Situations Fund (PM-CARES Fund), an official statement said.

Coronavirus India News LIVE Updates

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show

Coronavirus pandemic | IndusInd Bank pledges Rs 30 crore towards COVID-19 relief efforts

IndusInd Bank said it has supplied relief materials such as face masks, hand sanitisers and gloves to the affected areas to and is also working on facilitating personal protective equipment (PPE) for medical officials on duty.

Related stories

Trending news